Close

Packaging & Labelling

The $12.50b Potential of Pharmaceutical Packaging By 2033

The pharmaceutical sector significantly impacts global and regional economies, continually evolving through various industry trends. Packaging plays a vital role in this sector. Currently, the packaging ensures patient safety by providing essential product information, tamper resistance, and traceability. Pharmaceutical packaging...

Pharma Embraces Sustainability With Biodegradable Packaging

The worldwide demand for biodegradable pharmaceutical packaging is set for significant growth. As per  the forecast the market size will rise dramatically from USD 83.46 billion in 2023 to almost USD 335.82 billion by 2032. This surge, with a...

Balancing Safety And Sustainability In Pharma Packaging

The evolution of pharma packaging has always mirrored the healthcare sector's needs. Pharmaceutical companies prioritize packaging that: Meets storage specifications to keep drugs uncontaminated Complies with stringent regulations Facilitates efficient market distribution During the peak of COVID-19, these traits were...

Pharmaceutical Packaging Market To Reach $464.4 Billion

Experts forecast substantial growth in the global pharmaceutical packaging sector. Market value is predicted to rise from US$ 133.6 billion in 2022 to an impressive US$ 464.4 billion by 2031. This surge corresponds to a notable CAGR of 14.8%...

Leveraging Contract Packaging For Greener Pharma Solutions

GlobalData's analysis happens to reveal quite a significant uptick in the mention of emissions within pharmaceutical company filings. In 2023, this keyword appeared 6,272 times—a 33% increase from the previous year and a staggering 542% rise from 2016. This...

How E-Commerce Growth Is Shaping Cold Chain Packaging Needs?

The rise of global trade has significantly boosted the need for cold chain logistics to ensure the safe transport of perishable items and e-commerce products like pharmaceuticals, food, and beverages. A surge in consumer awareness and demand for fresh,...

Parenteral Packaging Changing Due To The Current E&L Issues

In mid-2018, nitrosamine content, also called NDMA, was found to go beyond the guidelines when it came to the daily intake limits of a hypertension medicine that is widely used and has potentially carcinogenic effects for patients. What thereafter...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »